The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Medimmune Ventures, Inc. since year 2005.
The trader's CIK number is 1291884.
At the time of this reporting, Medimmune Ventures, Inc. is the 10% Owner of G1 Therapeutics, Inc. .
(stock ticker symbol GTHX).
See this page for all insider trading activities at G1 Therapeutics, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2017-12-15||GTHX||G1 Therapeutics, Inc.||Sale||200,000||19.75||3,950,000|
|2017-12-01||GTHX||G1 Therapeutics, Inc.||Sale||133,906||19.75||2,644,643|
|2017-11-20||GTHX||G1 Therapeutics, Inc.||Sale||200,000||20.01||4,002,000|
|2017-05-22||GTHX||G1 Therapeutics, Inc.||Buy||75,000||15.00||1,125,000|
|2015-06-30||CATB||Catabasis Pharmaceuticals Inc||Buy||223,439||12.00||2,681,268|
|2015-02-23||ITEK||Inotek Pharmaceuticals Corp||Buy||416,667||6.00||2,500,002|
|2014-04-01||AGTC||Applied Genetic Technologies Corp||Buy||75,735||12.00||908,820|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Medimmune Ventures, Inc. (10% Owner of G1 Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.